Breaking News Instant updates and real-time market news.

MMSI

Merit Medical

$56.25

0.4 (0.72%)

09:31
08/07/18
08/07
09:31
08/07/18
09:31

Merit Medical downgraded to Underperform from Buy at BofA/Merrill

BofA/Merrill analyst Bob Hopkins double downgraded Merit Medical to Underperform from Buy citing valuation and maintained a $64 price target on shares. Hopkins said the margin expansion story is priced in and recent management changes should be considered.

  • 07

    Aug

  • 08

    Aug

  • 14

    Aug

  • 15

    Aug

  • 27

    Sep

MMSI Merit Medical
$56.25

0.4 (0.72%)

07/24/18
PIPR
07/24/18
NO CHANGE
Target $58
PIPR
Overweight
Merit Medical transition to sizable mid-cap player continues, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says Merit Medical Systems' Q2 beat expectations and that while management lowered its full year adjusted gross margin outlook by about 100 basis points, they more importantly increased their organic revenue outlook by roughly 250 basis points at the mid-point of the range. The strength in the core business was broad-based across products and geographies, O'Brien tells investors in a research note. He notes that management anticipates benefiting from a competitor supply disruption during the remainder of the year but is taking a conservative approach to this opportunity. The analyst thinks Merit continues its transition to a sizable mid-cap player in the med tech industry. He keeps an Overweight rating on the shares with a $58 price target.
07/24/18
ADAM
07/24/18
NO CHANGE
Target $70
ADAM
Buy
Merit Medical price target raised to $70 from $60 at Canaccord
Canaccord analyst Jason Mils raised his price target on Merit Medical to $70 from $60 following Q2 results. The analyst noted the company delivered solid upside to expectations and he sees strong momentum in the business. He sees multiple tailwinds that could drive more upside, including increasing operating leverage, solid trends in core businesses, and supply issues at a competitor. Mills reiterated his Buy rating on Merit Medical shares.
07/24/18
NEED
07/24/18
NO CHANGE
Target $67
NEED
Buy
Merit Medical price target raised to $67 from $54 at Needham
Needham analyst Mike Matson raised his price target on Merit Medical to $67 and kept his Buy rating after its better than expected Q2 results. The analyst notes that organic revenue growth has improved relative to Q1 despite the difficult comps and gross margins grew 60bps, even though he expected a higher rate of expansion. Matson anticipates Merit Medical to further improve in the second half of 2018 as comps ease and continued product shortage at Terumo benefits the company. The analyst also cites the positive impact from the "recent accretive acquisitions, manufacturing efficiencies, and higher margin product launches".
07/24/18
BRRR
07/24/18
NO CHANGE
Target $61
BRRR
Outperform
Merit Medical price target raised to $61 from $50 at Barrington
Barrington analyst Michael Petusky raised his price target on Merit Medical shares to $61 from $50 after the company's Q2 revenue topped his "Street-high" estimate and the company increased its FY18 guidance, stating that Merit "clearly continues to have a lot of momentum." Management still sees gross margins improving in 2018, but not at the level previously expected, Petusky additionally noted. He maintains an Outperform rating on Merit Medical.

TODAY'S FREE FLY STORIES

COG

Cabot Oil & Gas

$25.55

-0.28 (-1.08%)

11:45
11/15/18
11/15
11:45
11/15/18
11:45
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

11:45
11/15/18
11/15
11:45
11/15/18
11:45
General news
U.S. blue chips remain under pressure »

U.S. blue chips remain…

PM

Philip Morris

$84.99

-0.52 (-0.61%)

, BTI

British American Tobacco

$35.46

-1.05 (-2.88%)

11:41
11/15/18
11/15
11:41
11/15/18
11:41
Hot Stocks
FDA proposes steps to prevent flavored tobacco access, ban menthol cigarettes »

FDA Commissioner Scott…

PM

Philip Morris

$84.99

-0.52 (-0.61%)

BTI

British American Tobacco

$35.46

-1.05 (-2.88%)

MO

Altria Group

$58.38

-0.71 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$8.25

0.36 (4.56%)

11:35
11/15/18
11/15
11:35
11/15/18
11:35
Options
McDermott put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFT

Luxoft

$35.44

-3.3 (-8.52%)

11:33
11/15/18
11/15
11:33
11/15/18
11:33
Downgrade
Luxoft rating change  »

Luxoft downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TDY

Teledyne

$221.27

1.165 (0.53%)

11:31
11/15/18
11/15
11:31
11/15/18
11:31
Hot Stocks
Teledyne awarded $7.51M Navy contract »

Teledyne Microwave…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:30
11/15/18
11/15
11:30
11/15/18
11:30
Conference/Events
Leerink healthcare analysts to hold an analyst/industry conference call »

Analysts discuss the U.S.…

MDU

MDU Resources

$25.86

-0.265 (-1.01%)

11:30
11/15/18
11/15
11:30
11/15/18
11:30
Hot Stocks
MDU Resources increases quarterly dividend »

The MDU Resources Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$199.90

-2.53 (-1.25%)

11:29
11/15/18
11/15
11:29
11/15/18
11:29
Periodicals
Goldman Sachs CEO 'outraged' by 1MDB scandal, Bloomberg reports »

Goldman Sachs CEO David…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$78.25

-0.65 (-0.82%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Options
XPO Logistics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$32.50

-1.2 (-3.56%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Biohaven Pharmaceutical management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 27

    Nov

EVFM

Evofem

$3.44

(0.00%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Evofem to hold a key opinion leader event »

Management hosts a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 16

    Nov

  • 19

    Nov

  • 27

    Nov

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Morgan Stanley healthcare analysts to hold a luncheon »

Healthcare Analysts host…

SPLK

Splunk

$99.00

1.15 (1.18%)

, SAP

SAP

$104.09

0.23 (0.22%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Wedbush enterprise software analyst to hold a luncheon »

Enterprise Software…

SPLK

Splunk

$99.00

1.15 (1.18%)

SAP

SAP

$104.09

0.23 (0.22%)

ORCL

Oracle

$49.62

0.78 (1.60%)

PANW

Palo Alto Networks

$171.57

-5.26 (-2.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 19

    Nov

  • 26

    Nov

  • 29

    Nov

  • 29

    Nov

  • 05

    Dec

  • 06

    Dec

  • 10

    Dec

  • 09

    Jan

  • 10

    Jan

LOXO

Loxo Oncology

$147.40

3.71 (2.58%)

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
Loxo Oncology management to meet with Morgan Stanley »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

11:25
11/15/18
11/15
11:25
11/15/18
11:25
Conference/Events
RBC Capital software analysts to hold a group luncheon »

Software Analysts Hedberg…

MO

Altria Group

$58.61

-0.48 (-0.81%)

, BTI

British American Tobacco

$35.55

-0.96 (-2.63%)

11:22
11/15/18
11/15
11:22
11/15/18
11:22
Hot Stocks
CVS 'applauds' FDA announcement to restrict flavored tobacco products »

CVS Health (CVS)…

MO

Altria Group

$58.61

-0.48 (-0.81%)

BTI

British American Tobacco

$35.55

-0.96 (-2.63%)

PM

Philip Morris

$85.26

-0.25 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
11/15/18
11/15
11:20
11/15/18
11:20
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/15/18
11/15
11:17
11/15/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/15/18
11/15
11:16
11/15/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$34.69

0.46 (1.34%)

, QRVO

Qorvo

$63.65

0.77 (1.22%)

11:15
11/15/18
11/15
11:15
11/15/18
11:15
OnTheFly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

MYL

Mylan

$34.69

0.46 (1.34%)

QRVO

Qorvo

$63.65

0.77 (1.22%)

LITE

Lumentum

$39.14

0.29 (0.75%)

AAPL

Apple

$188.37

1.56 (0.84%)

ATNX

Athenex

$10.80

0.52 (5.06%)

PCG

PG&E

$19.54

-6.12 (-23.85%)

HZNP

Horizon Pharma

$20.53

-0.7 (-3.30%)

PYPL

PayPal

$84.29

0.24 (0.29%)

WP

Worldpay

$82.00

-0.71 (-0.86%)

FDC

First Data

$18.00

0.17 (0.95%)

SQ

Square

$70.75

0.9 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 26

    Nov

  • 27

    Nov

  • 12

    Dec

  • 18

    Dec

  • 18

    Dec

  • 03

    Mar

MTOR

Meritor

$15.36

-1.95 (-11.27%)

11:12
11/15/18
11/15
11:12
11/15/18
11:12
Recommendations
Meritor analyst commentary  »

Meritor earnings report…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 13

    Dec

AAPL

Apple

$188.71

1.9 (1.02%)

, LITE

Lumentum

$39.27

0.42 (1.08%)

11:12
11/15/18
11/15
11:12
11/15/18
11:12
OnTheFly
Morgan Stanley says buy Apple on any weakness amid supply chain ‘noise’ »

Calling the recent…

AAPL

Apple

$188.71

1.9 (1.02%)

LITE

Lumentum

$39.27

0.42 (1.08%)

QRVO

Qorvo

$63.84

0.96 (1.53%)

GLW

Corning

$31.59

0.18 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

KBH

KB Home

$17.07

-3.73 (-17.93%)

11:10
11/15/18
11/15
11:10
11/15/18
11:10
Options
KB Home puts lead calls 4:1 and implied volatility spikes to 52-week highs »

KB Home puts lead calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
11/15/18
11/15
11:01
11/15/18
11:01
General news
Crude inventories for week of November 9 »

Crude oil inventories…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.